Baker Bros. Advisors’ Latest Moves Involve Genomic Health, Inc. (GHDX), & Celsus Therapeutics PLC (ADR) (CLSXD)

Julian Baker and Felix Baker's Baker Bros. Advisors have disclosed in a new filing with the SEC adding approximately 4,100 shares to their stake in Genomic Health, Inc. (NASDAQ:GHDX). Julian and Felix Bakers received the securities instead of director retainer fees of $10,000. Baker Bros. currently holds a total of over 13.84 million shares of the company. Genomic Health, Inc. (NASDAQ:GHDX) Molecular diagnostics company, Genomic Health, Inc. (NASDAQ:GHDX) is engaged in the development of genomic-based laboratory services that analyze the biology of cancer for providing individualized treatment decisions. Earlier, the company entered into an agreement with Almac Group, under the terms of which, Genomic will license Almac's technology to develop and commercialize a multi-gene test to predict benefit from chemotherapy drugs. For the third quarter of 2013, Genomic Health, Inc. (NASDAQ:GHDX) reported revenue of $66 million, up from $58.6 million in the same period of 2012. The company also posted a net income of $0.5 million, down from $3.7 million, a year ago. Baker Bros. are some of the largest shareholders of Genomic Health, Inc. (NASDAQ:GHDX). Millennium Management, led by Israel Englander, in its latest 13F, disclosed ownership of some 195,300 shares, worth $5.97 million. Another shareholder is Ken Griffin's Citadel Investment Group, which held 108,700 shares, with a reported value of $3.32 million. Aside from Genomic Health, Inc. (NASDAQ:GHDX), Baker Bros. also recently disclosed holding approximately 5.26 million shares of Celsus Therapeutics PLC (ADR) (OTCMKTS:CLSXD). The stake amasses 13.1% of the company's common stock. Celsus Therapeutics is a development company that specializes on novel anti-inflammatory drugs. Earlier, Baker Bros. reported about trimming their stake in MEI Pharma Inc (NASDAQ:MEIP) to some 746,500 shares, from 1.13 million held previously. Disclosure: none Recommended Reading: Eric Bannasch’s Cadian Capital Increases Stake in COMSCORE, Inc. (SCOR) to 10% Bandera Partners Reveals Moves into Tandy Leather Factory, Inc. (TLF), Ambassadors Group Inc (EPAX), & Morgan’s Foods, Inc. (MRFD) Ardsley Partners Further Trims Stake in Saba Software, Inc. (SABA)
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 30 percentage points in 13 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!